Retail

The Global Allergy Market In 2025: ‘Growth Is Back, But Not Like Before’

 
• By 

The global allergy market is “expanding again but on new terms, driven by a mix of regional strength, evolving consumer behaviors, and an increasingly diverse competitive field,” according to the latest IQVIA Consumer Health analysis.

English Pharmacies Can Now Offer Free Emergency Contraception

 
• By 

Women in England are now eligible to access the morning after pill for free from their community pharmacy. Maxwellia CEO Anna Maxwell welcomes the move, but warns that the service must be balanced with OTC options because “waiting, even for a free service, may simply not be an option.”

Tmall China: Massive OTC Growth Potential, ‘But We Don’t Have Enough Brands’

 
• By 

Tmall’s business development manager, Aline Hu, and founder of cross-border e-commerce specialist QIVA Global, Ellie Adams, offer advice to multinational consumer healthcare players looking to enter the potentially lucrative and growing Chinese consumer healthcare import market.

‘Where Life Is Experienced’ – Bayer And Karo On Winning In ‘Connected Commerce’

 
• By 

Bayer’s EMEA e-commerce and commercial director, Andrew Parker, and Karo Healthcare’s global skin health category director, Sally Perry, discuss how the consumer health industry can meet today's “connected consumers” on their omnichannel shopping journey.


Gen Z Longevity Trend Offers Hope For Stagnating Global OTC Market

 
• By 

HBW Insight reports from the opening session of Lynx2Market’s PharmaSynergyOTC event in Rome, Italy, featuring IQVIA Consumer Health, Euromonitor International and Amazon.

UK Retailer Marks & Spencer Expands Into OTC, Becomes PAGB’s 100th Member

 
• By 

“Our new range of own label medicines have now launched in store and that’s why we’ve partnered with PAGB, who provide expert regulatory and policy guidance and support in an evolving and complex sector,” explains the UK retail chain, which has become PAGB's 100th member.

Private Label ‘Smart Imitation’ Of National Brands’ Packaging Not So Wise In US OTC Drug Sector

 

First Insight survey with 1,267 US consumers showed 44% are more likely to try a private label product “marketed as a dupe of a high-end product.” Providers of OTC drugs as well as other medical products in US would tread on thin regulatory ice with the practice.

Moberg Nail Fungus Line Takes Lead In Norway As Firm Plots EU Expansion

 
• By 

Terclara - Moberg’s proprietary topical formulation of terbinafine for fungal nail - has established itself as the market leader in Norway just months after its OTC launch. The firm is now plotting its expansion to additional EU markets.


OTCs Are ‘Beacon Of Hope’ For Austrian Pharmacy

 
• By 

Just under half of Austrian pharmacists surveyed by Elpato Medien are “convinced that the OTC business will ensure the survival of their pharmacy.”

Germans Favor Bricks-And-Mortar Pharmacy Over Mail-Order For OTCs

 
• By 

Almost two thirds (62%) of respondents to an online survey said they would rather buy non-prescription medicines in a local pharmacy than via a mail-order pharmacy, Pharma Deutschland reports.

JCPenney’s Online Beauty Shopper Conversion, Order Value Jump Thanks To Virtual Try-On

 

Retailer JC Penney Company, Inc.’s use of Revieve Inc.’s virtual try-on and beauty advisor tools has driven significant increases in online engagement, average order rates and conversion rates for makeup, skin and hair care versus the retailer’s other e-commerce products.

False Advertising Challenges To OTC Phenylephrine Efficacy Ineffective Against Federal Preemption

 

Although FDA concluded OTC oral phenylephrine is ineffective as a nasal decongestant in doses up to highest studied level, federal preemption precludes challenges to agency’s regulation of labeling for phenylephrine and other Rx and OTC drugs, according to recent decision in New York federal court.


Bausch + Lomb Results Enhance Acquisition Image

 

Firm’s future, as a separate business nearly 90% owned by Bausch Health, or as a standalone with different ownership or one not controlled by a majority owner, claims high profile in analysts’ comments and predictions. B+L is in the driver’s seat, they say.

Mucinex Promotes Romance To US Consumers, Launches Something To Chew On For Children

 

Reckitt backs up prediction for strong sales during current quarter with advertising featuring a beauty queen and a line extension for Mucinex, one its strongest US consumer health product lines.

US FDA’s Petition Procedures No Place For OTC Acetaminophen Pediatric Dosing Enforcement

 

Requests for “enforcement actions are not within the scope of FDA’s citizen petition procedures,” CDER says, rejecting petition dosing device firm Parenteral Technologies submitted as it prepares for workshop on Pediatric Research Equity Act requirements for OTC NDA sponsors.

GSK Tab To Clear Zantac Litigation Ledger Of 93% Of Complaints Pending In State Courts: $2.2Bn

 

UK pharma also reaches agreement in principle, subject to DoJ approval, to pay $70m to resolve a whistleblower complaint filed by Valisure, the testing lab which in 2019 raised concerns about a potential link between the use of drugs containing ranitidine, a histamine-2 blocker, and cancer.


Nozzle At Tip Of Problems For Florida Eye Drop Firm: US FDA Warns Of GMP, Monograph Violations

 

Regenerative Processing replaces nozzle to prevent backflow for its Regener-Eyes drops but FDA warning states numerous questions about sterility at the firm’s plant and about its procedures and systems for preventing microbial contamination.

OcuSoft Retains Retaine Brand Name, Looks Askance At Eyeleve Marketer’s Reference

 

After launching Retaine MGD Advanced, OcuSoft says a release by Bruder Healthcare referenced Retaine MGD trademark and statements from a previous OcuSoft announcement about the original product attributed to an optometrist. B+L, Rohto brand and homeopathic firm Relief Products also make US OTC eye care space moves.

Edgewell Stirs Leadership, Brewing Industry Veteran Executive Leads North America Business

 

Jessica Spence joins as North American president while CFO Dan Sullivan becomes COO and Francesca Weissman, finance and business strategy SVP, adds CFO to her title in latest executive office changes by the marketer of brands including Schick men's and women’s shaving, Playtex, Stayfree, Carefree and o.b. feminine care and Banana Boat and Hawaiian Tropic sun care.

US FDA Forecasts Monograph Program Activities As Overhaul Transitions From Construction Phase

 

Nonbinding forecast, fourth for the program, includes risks associated with codeine-containing cough medicine as a topic FDA will include in ongoing evaluation of GRASE for pediatric cough cold drug products marketed under monograph for cold, cough, allergy, bronchodilator and anti-asthmatic OTC drugs.